observational, non-interventional study in 120 patients with drug-resistant partial epilepsy, comprising two phases: a 3-month retrospective and a 6-month prospective. As control group, 120 patients with controlled partial epilepsy will be enrolled. The objective of the study is to describe the burden of illness in this epileptic population both in terms of costs and of quality of life. Costs and quality of life will be also compared between the two populations.
observational, non-interventional study in 120 patients with drug-resistant partial epilepsy, comprising two phases: a 3-month retrospective and a 6-month prospective.
Study Type
OBSERVATIONAL
Enrollment
240
non-interventional study
total cost (direct and indirect) per patient per year of drug-resistant partial patients collected in the retrospective and in the prospective phase
Time frame: 9 months: a 3-month retrospective and a 6-month prospective.
The primary endpoint is the total cost (direct and indirect) per patient per year of controlled patients collected in the retrospective and in the prospective phase.
Time frame: 9 months. a 3-month retrospective and a 6-month prospective.
the difference between the group of drug-resistant patients and the control group as regards each single resource consumptions and the direct and indirect costs (single and total)
Time frame: 9 months: a 3-month retrospective and a 6-month prospective.
The comparison of the seven multi-item scores and the overall score of QOLIE-31 (Quality of life in Epilepsy -31 items) questionnaire between the two patients groups
Time frame: questionnaire administerd at visit 1 only
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.